Suppression of Serum Interferon-gamma Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus
Cesaroni, M., L. Seridi, M. J. Loza, J. Schreiter, K. Sweet, C. Franks, K. Ma, et al. 2021. “Suppression of Serum Interferon-Gamma Levels As a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus”. Arthritis Rheumatol 73: 472-77.